Orchid Pharma: FY26 Revenue at ₹811.33 Mn

Orchid Pharma Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results include a modified opinion for consolidated financial results and an unmodified opinion for standalone financial results. The company's revenue from operations for the year ended March 31, 2026, stood at ₹811.33 million. The board also approved the appointment of the Internal Auditor for FY 2026-27.